Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema

Phase 2 Completed 57 enrolled Tehran University of Medical Sciences Farabi Eye Hospital · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to determine whether oral losartan is effective in the treatment of diabetic macular edema (DME) as an adjuvant for intravitreal bevacizumab (IVB).

Timeline

Start: 2015-06
Primary completion: 2016-06
Completion: 2016-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Losartan	Other / unclassified	50 mg	Oral
Background	Bevacizumab	Monoclonal antibody	—	Intravitreal

Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema

Summary

Timeline

Drugs

Indications